New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
about
Microemulsions for oral administration and their therapeutic applicationsRavuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity.Safety data on 19 vehicles for use in 1 month oral rodent pre-clinical studies: administration of hydroxypropyl-ß-cyclodextrin causes renal toxicity.Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallizationOral delivery of peptides and proteins using lipid-based drug delivery systems.Approaches to erythrocyte-mediated drug delivery.Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.Photosensitizer in lipid nanoparticle: a nano-scaled approach to antibacterial function.Insoluble drug delivery strategies: review of recent advances and business prospects.Self-Microemulsifying Drug Delivery Systems: An Attractive Strategy for Enhanced Therapeutic Profile.Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen."Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches.Review and analysis of FDA approved drugs using lipid-based formulations.Systematic development of optimized SNEDDS of artemether with improved biopharmaceutical and antimalarial potential.Role of nanoparticle size, shape and surface chemistry in oral drug delivery.SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization.Development of Solid SEDDS, V: Compaction and Drug Release Properties of Tablets Prepared by Adsorbing Lipid-Based Formulations onto Neusilin® US2.Optimization of self nanoemulsifying drug delivery system for poorly water-soluble drug using response surface methodology.Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs.Characterization of colloidal structures during intestinal lipolysis using small-angle neutron scattering.Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution.Using Environment-Sensitive Fluorescent Probes to Characterize Liquid-Liquid Phase Separation in Supersaturated Solutions of Poorly Water Soluble Compounds.Understanding biorelevant drug release from a novel thermoplastic capsule by considering microstructural formulation changes during hydration.Modulation of lipid digestibility using structured emulsion-based delivery systems: comparison of in vivo and in vitro measurements.Development and in vitro evaluation of an oral SEDDS for desmopressin.Preparation, in-vitro and in-vivo evaluation of spray-dried ternary solid dispersion of biopharmaceutics classification system class II model drug.Design, synthesis, and biological evaluation of β-lactam antibiotic-based imidazolium- and pyridinium-type ionic liquids.In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems
P2860
Q29307905-43D99E2F-6BD5-4013-96C0-F776EAD81E19Q33713176-2D5F2E56-DEEA-474F-B890-3A931D48F760Q35626401-368055E6-F749-48D0-A798-5CA3D8B2A78DQ36009014-6150A55F-0854-4A8A-8BB4-178BC078AEFEQ38035036-6D9AA03D-43FC-4CA4-B93F-7C7DA687EDCBQ38189095-B32F460F-0485-4EAB-9F69-CD1F433E0A10Q38199539-D77754AB-2C8D-4FB1-B574-F31B78417E19Q38628101-9F21DDCD-F7B4-411F-B6FA-B6E7506B2D05Q38637003-AD84F682-3A6E-4B7F-A379-8EAE3D53AAACQ38887547-CE239BE1-F95E-4526-9824-C51805AEA895Q38926514-045410AD-0454-455C-8756-442EC75326AFQ38967883-454C05F6-5DCB-4B39-806C-576D8F58E086Q39114475-740195AC-7D03-46F3-87EA-63C86D0EBD02Q39152233-F5057EA6-69F7-4A22-B54C-760A3932131EQ39411779-3D0AC3FF-255B-4B58-AB77-EC7FFC379859Q40737520-E313468D-42E1-46FA-BE84-FF50D48DB169Q41674798-57554512-21B9-495C-8018-24D9A8809283Q41777003-DC148CF5-69E4-4F72-BEDD-DB10A4D42FADQ42216132-43BC3CB1-2ABA-4F3B-9389-CF88E424D280Q43512468-31C8B17A-16B3-4B59-AE87-9F39B78ED10DQ44062316-1D13A819-068D-4012-98AB-9B669EC8F30BQ45301586-13E65376-F9BC-492F-A42E-DA4C28D34E70Q45887220-95A20DAB-1BCF-4726-A8EB-2128360A6846Q46049295-D51504C9-AF5C-4E6A-81E1-D2805E051A14Q47844017-B3DFDBD4-7FB1-478F-BEE7-814755048083Q52621803-8EA91E81-5579-44B8-A8A9-ACB65E7D76D4Q53225531-4958C8FA-FEF5-4730-8EFB-5C6E61494CACQ53637145-EC79FF31-DE41-43C9-A90F-7F6D524DC9A2Q54364540-70CC884A-8498-4362-B643-1CFE6F48D439Q58199028-B2BF782C-FB18-4909-9A75-5436B98206AC
P2860
New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
New perspectives on lipid and ...... ivery of poorly soluble drugs.
@en
New perspectives on lipid and ...... ivery of poorly soluble drugs.
@nl
type
label
New perspectives on lipid and ...... ivery of poorly soluble drugs.
@en
New perspectives on lipid and ...... ivery of poorly soluble drugs.
@nl
prefLabel
New perspectives on lipid and ...... ivery of poorly soluble drugs.
@en
New perspectives on lipid and ...... ivery of poorly soluble drugs.
@nl
P2860
P1476
New perspectives on lipid and ...... ivery of poorly soluble drugs.
@en
P2093
Anayo Ogbonna
P2860
P304
P356
10.1111/J.2042-7158.2010.01107.X
P577
2010-11-01T00:00:00Z